Navigation Links
Pharmos Corporation Reports 2009 First Quarter Results
Date:5/12/2009

to $147,157 in other expense in 2009. The majority of the decrease is from decreased interest income of $125,413 from a decline in cash, cash equivalents and short term investments. We also recorded a $30,685 translation loss on assets held in Israel due to currency translation fluctuations. In the first quarter of 2009 the Company recorded $119,838 in interest expense related to the issuance of $4,000,000 in convertible debentures issued on January 3, 2008.

About Pharmos Corporation

Pharmos discovers and develops novel therapeutics to treat a range of indications including specific diseases of the nervous system such as disorders of the brain-gut axis (IBS), pain/inflammation, and autoimmune disorders. The Company's only product in development, dextofisopam, is undergoing Phase 2b testing in IBS patients. Dextofisopam has completed a Phase 2a IBS study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0.033). The Company also has a proprietary technology platform focusing on discovery and development of synthetic cannabinoid compounds with a focus on CB2 receptor selective agonists. Various CB2-selective compounds from Pharmos' pipeline have completed preclinical studies targeting pain, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and other disorders. These are available for licensing / partnering. On February 18, 2009, Pharmos Corporation and its Israeli subsidiary, Pharmos Ltd., entered into an Asset Purchase Agreement with Reperio Pharmaceuticals Ltd. for the sale of the patent rights and technical know-how related to the compound known as PRS-639,058 and certain follow-on molecules.

Safe Harbor Statement

Statements made in this press release related to the business outlook and future financial performance of Pharmos, to the prospective market pe
'/>"/>

SOURCE Pharmos Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pharmos Completes Private Placement - Raises $1.8 Million
2. Pharmos Corporation Announces Receipt of Nasdaq Delisting Determination
3. Pharmos Corporation Announces Modification to Dextofisopam Trial Size, Objectives Can Still Be Achieved
4. Pharmos Corporation Announces Receipt of Nasdaq Noncompliance Letter
5. Pharmos Corporation Reports 2008 Third Quarter Results
6. Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results
7. Pharmos Restructures Operations in Israel
8. Volcano Corporation Presentation at JMP Conference to be Webcast
9. Medical Care Corporation Enables Early Detection of Memory Loss Due to Alzheimers Disease
10. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
11. Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporations Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... small protein beta-amyloid is strongly associated with Alzheimer,s disease; ... this peptide is the causal agent of the onset ... such confirmation is that beta-amyloid is not harmful when ... is when it self-assembles to form the so-called amyloid ... target, beta-amyloid alone, but with multiple ones because each ...
(Date:10/1/2014)... research co-funded by the Engineering and Physical Sciences ... of the UK,s vital industrial control systems which ... electricity grid, and the rail network. , ... from hackers or malware infiltrating the systems behind ... Institute in Trustworthy Industrial Control Systems (RITICS), based ...
(Date:10/1/2014)... Familylifeinsurancequotes.org has released a new blog post explaining ... , Senior citizens can qualify for affordable term life ... who are over 50 years old. Some term life ... examination. , Term life insurance with a simplified issue ... Having life insurance during retirement is important for covering ...
(Date:10/1/2014)... Lifeinsurance-policy.com has released a new blog post ... for smokers. , Smoking will always have a negative ... the best method to find affordable coverage. Insurance brokerage ... coverage. , Whole life insurance premiums will be ... the coverage is permanent, the initial rates are ...
(Date:10/1/2014)... FARMINGTON, Conn. (PRWEB) October 01, 2014 ... its company, including a redefined mission and visual ... the power of partnering with them to create ... more agile brand that focuses on empowering customers ... benefits communications. , The crown jewel of the ...
Breaking Medicine News(10 mins):Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:Farmington Company Launches Rebrand and New Positioning 2
... SAN DIEGO, March 11 NuVasive, Inc. (Nasdaq: ... developing products for minimally disruptive surgical treatments for the ... is scheduled to present at the Cowen & Company ... Place in Boston, Massachusetts on Wednesday, March 18, 2009, ...
... disability, quality of life similar on levodopa or pramipexole, ... Two drugs -- levodopa and pramipexole -- used to ... disadvantages, but their overall impact appears to even out ... conclusion of a new study that included hundreds of ...
... In the end the objective was clear: a European Research ... findings and technology would be as natural as the free ... the year 2020. , Although there is still a long ... start has been made in many areas. This was apparent ...
... Karp and Ron Fink Open Their Door at CareMinders Home ... Need of Their Services.WEST BLOOMFIELD, Mich., March 11 It,s ... Fink turned the lights on in their West Bloomfield offices ... impact in the community.While very few startup companies have been ...
... the congress of the European Association of Cardiovascular Prevention ... a five-year period of heart-healthy political activity in Europe ... the European Heart Health Charter to the European Parliament. ... joint organiser Professor Joep Perk. "Now is the time ...
... French . , Montreal, March 11, 2009 Thrill-seeking ... of cannabis (DUIC) and engage in reckless driving, according to ... journal Accident Analysis and Prevention , men who are ... taking the wheel after consuming cannabis more often than older ...
Cached Medicine News:Health News:NuVasive to Present at Cowen and Company 29th Annual Healthcare Conference 2Health News:Parkinson's Treatment Drugs Even Out Over Long Term 2Health News:Science as a pioneer 2Health News:Science as a pioneer 3Health News:There is No Place Like CareMinders Home Care and the Dedication and Commitment of the Owners 2Health News:EuroPRevent 09: Changing hearts and minds in the drive to prevent cardiovascular disease 2Health News:EuroPRevent 09: Changing hearts and minds in the drive to prevent cardiovascular disease 3Health News:Study finds cannabis use, dangerous driving behaviors interrelated 2
(Date:10/1/2014)... Oct. 1, 2014  Express Scripts (NASDAQ: ... 2015 Express Scripts Medicare ® Prescription Drug Plans ... Walgreens (NYSE: WAG ) (NASDAQ: ... and clinical support  for their Medicare dollars. ... Value or Choice plans for ...
(Date:10/1/2014)... 1, 2014 Ardelyx, Inc. (NASDAQ: ... company focused on cardio-renal, gastrointestinal and metabolic ... 371 patient Phase 2b clinical trial evaluating ... syndrome (IBS-C).  Results from this study demonstrated ... IBS-C symptoms for tenapanor-treated patients compared to ...
(Date:9/30/2014)... , Sept. 30, 2014 /CNW/ - Protecting the health and safety ... Health Canada uses the appropriate powers and tools at its disposal ... safety and quality standards. To that end, Health ... stop the import into Canada of all ... . They are: , Apotex Pharmachem India Pvt ...
Breaking Medicine Technology:Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 3Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2
... Pacific Bridge Medical will be attending the Medical ... 28-30, 2010, at the Donald E. Stephens Convention ... is part of a national conference series for ... affairs within the pharmaceutical and medical device manufacturing ...
... 23 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) ... M. Bate to its Board of Directors. "We ... to our Board of Directors.  With experience, vision and proven ... to take on this important role in the company," said ...
Cached Medicine Technology:Asian Medical Markets Expert to Attend the MD&M Midwest Conference 2BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors 2BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: